A VA Veteran Health and Use of Health Care Data Findings Report published in March found that the rate of veterans enrolled in VA health care who identified as smokers dropped nearly 20% in 21 ...

On Wednesday, BTIG analysts reaffirmed their Buy rating and maintained a $210 price target on Chart Industries (NYSE: NYSE: GTLS).This decision follows the company’s announcement of plans to ...

On Wednesday, JPMorgan analysts maintained a Neutral rating for Chart Industries (NYSE: NYSE: GTLS), affirming a price target of $194.00.This follows the announcement of an all-stock merger of ...

Veterans with a 70% VA disability rating and dependants will receive up to $2,028.19 monthly in 2025. The tax-free payment ...

For veterans living on Guam, the average wait time to get a disability rating is seven months, which is “unacceptable,” according to Del. James Moylan, whose request led to a ...

The Van Zandt VA Medical Center has received a five-star quietness rating from Becker’s Hospital Review. This rating was awarded based on results from the Consumer Assessment of Healthcare ...

On June 4, analysts at BTIG reiterated a Buy rating and maintained a $210 price target on Chart Industries Inc. (NYSE:GTLS).The research firm has reiterated its bullish stance on the company ...

On Thursday, UBS analysts maintained their Buy rating on Chart Industries (NYSE: GTLS) stock, with a price target of $225.00, well above the current trading price of $146.70.The stock, which has shown ...

HOUSTON, June 17, 2025 (GLOBE NEWSWIRE) -- In a powerful show of support for America’s veterans, leading Diagnostic Radiologist Dr. Andrew Gomes has announced the creation of the Dr. Andrew ...

ALTOONA, Pa. (WTAJ) — At the James E. Van Zandt VA Medical Center, ... The Altoona-based facility was awarded a five-star quietness rating from Becker’s Hospital Review, ...

NVIDIA Corp. research and ratings by Barron's. View NVDA revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

The FDA has declared psychedelic research a “top priority,” while Texas committed $50 million to ibogaine trials for veterans. Attorney Matthew Zorn, long critical of federal drug secrecy, has ...